The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (15 analysts) rates it hold, with a mean price target of $325.
RenaissanceRe Holdings Ltd RNR
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally.
read at $323.49
RenaissanceRe Holdings Ltd holds its Markup at $323.49.
- PHPhase · the trend structure carries the Markup label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Markup |
| Quantitative state | The statistical read favours the sellers, held for 17 days |
| Price | $323.49 |
| Valuation | 5.61 trailing · 7.89 forward price to earnings |
| Values screen | FAIL · score 30.0 |
| Beta | 0.17 |
The opportunity · what the numbers say it is worth
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Both our model and the analysts see meaningful upside from here.
| Revenue growth | -13.20% |
| Profit margin | 23.58% |
| Debt to equity | 12.21 |
| Analyst consensus | Hold · 15 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its excluded industry: insurance - reinsurance. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Excluded industry: Insurance - Reinsurance Fail
- Debt load Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
- Interest-bearing cash Interest-bearing cash and securities are of assets, above the one-third limit. Fail
- Receivables Money owed to the company is of assets, above the 49% limit. Fail
- Revenue purity of revenue comes from non-compliant sources, over the 5% line. Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Reinsurance looks cheap until ethics get involved
When a hurricane hits Florida or a wildfire tears through California, the bill eventually lands with firms like this one. RenaissanceRe sits in that chain, taking premiums today and paying out when disasters strike. The numbers show a forward P/E of 7.9x and a 23 percent ROE, yet revenue fell 37 percent last year.
We pass. The ethical screen rules out reinsurance outright, and no valuation discount changes that stance. Narrow moat, hold-rated by analysts and a slim margin of safety do not outweigh the industry exclusion.
Cyclical earnings can look attractive on low multiples right before claims spike, and Bermuda domicile adds another layer of regulatory and tax uncertainty. The market is not mispricing the business so much as correctly tagging the structural risks.
Analysis, not advice.
| Forward P/E | 7.9x very cheap relative to earnings |
| Trailing P/E | 5.6x very cheap relative to earnings |
| Revenue growth | -13.2% revenue is shrinking |
| Profit margin | 23.6% healthy profit margins |
| Return on equity | 21.5% an exceptional return on shareholder capital |
| Debt to equity | 0.12 minimal debt — a conservative balance sheet |
| Current ratio | 1.35 adequate liquidity, worth monitoring |
| Beta | 0.17 barely tracks the market's swings |
| Market cap | $13.4B |
| Employees | 1,040 |
The risks · The things to watch: its business and earnings are exposed to Bermuda and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Related securities · others in RNR's space worth a look
Screened names in the same industry · explore each on its own page.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 22%. Our forward projection puts the odds of a 10% gain over the next month near 16%. The street (15 analysts) rates it hold, with a mean price target of $325.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $295.95 | +0.2% | · | $1,002 | +0.2% |
| 2 months | $303.03 | -2.2% | · | $978 | -2.2% |
| 3 months | $290.95 | +1.9% | $0.41 | $1,020 | +2.0% |
| 6 months | $270.01 | +9.8% | $0.41 | $1,099 | +9.9% |
| 1 year | $242.17 | +22.4% | $1.21 | $1,229 | +22.9% |
| 2 years | $225.44 | +31.5% | $2.78 | $1,327 | +32.7% |
| 3 years | $188.95 | +56.9% | $4.31 | $1,592 | +59.2% |
| 5 years | $145.30 | +104.0% | $7.25 | $2,090 | +109.0% |
Historical returns from market close data. Past performance does not guarantee future results.